Both in Pharmaceuticals
Generate Biomedicines vs Stoke Therapeutics
Over the past year GENB returned −11.5% and STOK returned −5.5%; their daily moves had a correlation of 0.49.
GENB −11.5% STOK −5.5%Growth of $1, one year, split-adjusted
| Metric | GENB | STOK |
|---|---|---|
| Price | $13.92 | $27.44 |
| Market cap | $1.79B | $1.77B |
| Today | +0.51% | +1.67% |
| 1 month | +0.9% | +12.6% |
| 6 months | — | −17.5% |
| Year to date | — | −13.5% |
| 1 year | — | +5.1% |
| Revenue growth (YoY) | — | +5.9% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1065.2% | −654.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 62.8× |
| Net cash | $452.3M | $319.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 47.9% |
| Short % of float | 15.4% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).